Big blood savings: large trial in JAMA shows taking less blood for lab testing reduces #transfusions in intensive care PHRI.ca Population Health Research Institute 🇨🇦 ohri.ca/newsroom/story… #ottnews

Attending #Targets23? In the latest issue, Anup Joseph Devasia, Lancman, and @akeithstewart discuss the landmark Cancer Research article that introduced proteasome inhibition in #myeloma. bit.ly/45qyTmp Princess Margaret Cancer Centre AACR

Slide I showed at #IMS23 that got people’s attention. Myeloma treatment costs. #MedTwitter

Congratulations CMRG team on this recent publication! nature.com/articles/s4140…

Join us for Myeloma Seminar 3! 📚 Dr. Donna Reece and Suzanne Rowland, NP will further discuss on the interpretation of blood test results and MRI images Register now on Zoom to secure your spot. Don't miss out! Registration link: us06web.zoom.us/meeting/regist…

Wait. Canada has more docs per 1000 than the US? economist.com/united-states/…

Join us for an interactive seminar with Suzanne Rowland, NP on Zoom! In this month's seminar Suzanne will focus on how best to achieve optimal quality of life (QOL). Date: Thursday, January 25, 2024 Time: 5:00PM-6.30PM EST Registration Link: us06web.zoom.us/meeting/regist…

gsk.com/en-gb/media/pr…

gsk.com/en-gb/media/pr…

THANK YOU all for your support to the ⁦COMy⁩ - What an incredible success! ⁦IACH⁩ ⁦International Myeloma Foundation⁩ ⁦Multiple Myeloma RF⁩ ⁦AF3M Asso⁩ ⁦Myeloma Society⁩ ⁦Vincent Rajkumar⁩ ⁦@MyelomaTeacher - Cindy Chmielewski⁩ ⁦Myeloma Patients Europe⁩ ⁦Meral Beksac⁩

#Myeloma Paper of the Day: Analysis of Canadian Myeloma Research Group Database finds tandem autologous transplantation (vs. 1 ASCT) does not benefit high-risk myeloma patients (overall & in subgroups) in the maintenance era on either PFS or OS: pubmed.ncbi.nlm.nih.gov/38971462/. #mmsm

Thank you to the amazingly dedicated team and generous patients who made this possible. I hope CoMMpass keeps fueling new discoveries for years to come #mmsm Sagar Lonial MD @PedalheadPHX Hearn Jay Cho MD, PhD

Great to see this data on outcomes of TCE MM pts with belaPd from ⁦Canadian Myeloma Research Group⁩ in ⁦Blood Cancer Journal⁩ with ⁦Hamilton Health Sciences⁩ ⁦McMaster Research⁩ ⁦@ECRI_RESEARCH⁩ ⁦Myeloma Canada⁩ nature.com/articles/s4140…

#Myeloma Paper of the Day: ALGONQUIN trial subgroup analysis of belantamab/pom/dex in triple class exposed/refractory myeloma finds ORR 86.4% in TCE vs 84.9% in TCR patients, ≥VGPR of 64% vs 68%, median PFS 18.3 vs 19.6 mos, and OS NR vs 34.4 mos: pubmed.ncbi.nlm.nih.gov/39261451/. #mmsm

✨Join us for an unforgettable evening at the CMRG Gala with special guest Rick Mercer ! Don't miss your chance to support myeloma research and enjoy a night of entertainment, all for a great cause! 📅 October 18, 2024 📍 Toronto, Canada 🎟️Buy Tickets eventbrite.ca/e/first-cmrg-g…

CMRG meeting in Toronto being co-chaired by soon to be Hamilton Health Sciences faculty Alissa Visram with first talk being kicked off with Christopher Venner Canadian Myeloma Research Group Hamilton Health Sciences McMaster Research

Fortunate to have the great Marc S. Raab present to us in 🇨🇦 Canadian Myeloma Research Group

Thank you Rakesh Popat for coming to Canada and sharing your wisdom with Canadian Myeloma Research Group

Attending a fantastic Canadian Myeloma Research Group gala with none other than the fabulous Dr.McCurdy, #woMMen in myeloma, lucky to have incredible colleagues:)

Canada, UK, Germany: maybe we just need to form a global cooperative group with headquarters in Toronto:) with Rakesh Popat Marc S. Raab Canadian Myeloma Research Group CCTG